Eli Lilly tests antibody drug to halt COVID-19 spread in US nursing homes

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

INDIANAPOLIS: Eli Lilly and Co said on Monday (Aug 3) it started a late-stage trial testing whether one of its experimental COVID-19 antibody ...

LY-CoV555, which is being developed in partnership with Canadian biotech AbCellera, is already being studied as a treatment in patients who have contracted the disease. The nursing home trial will test whether it works prophylactically.

The elderly are at particularly high risk for the disease that has claimed more than 690,000 lives globally. To speed the study, the company has created mobile research units including retrofitted recreational vehicles that can be deployed in response to coronavirus outbreaks at nursing homes across the United States.LY-CoV555 belongs to a class of drugs known as monoclonal antibodies, which are among the most widely used biotechnology medicines. Regeneron Pharmaceuticals Inc and other drugmakers are testing similar treatments against COVID-19.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Regeneron says antibody cocktail prevents and treats COVID-19 in animalsRegeneron Pharmaceuticals Inc said on Monday that the COVID-19 antibody drug combination it is developing both prevented and treated the disease ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Nursing home's licence revoked over lapses, including failure to comply with Covid-19 safeguardsSINGAPORE - A nursing home has lost its licence after failing to comply with regulatory requirements, including the taking of Covid-19 precautionary measures.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Next big Covid-19 treatment may be manufactured antibodiesSAN FRANCISCO (REUTERS) - As the world awaits a Covid-19 vaccine, the next big advance in battling the pandemic could come from a class of biotech therapies widely used against cancer and other disorders - antibodies designed specifically to attack this new virus.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Covid-19 tests and quarantines: US colleges brace for an uncertain fallWASHINGTON (NYTIMES) - This month, many colleges in the United States plan to welcome back thousands of students into something they hope will resemble normal campus life.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

US economy needs more stimulus and more masks, Fed policymakers sayThe US economy, battered by a resurgence in the spread of COVID-19, needs increased government spending to tide over households and businesses and ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Britain to roll out millions of 90-minute COVID-19 testsMillions of COVID-19 tests able to detect the virus within 90 minutes will be rolled out to British hospitals, care homes and laboratories to ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »